Dr. Abdullah Shehab has 22 years of experience in Internal medicine, cardiology and interventional cardiology and medical education. Currently, he serves as the General Secretary of Emirates Cardiac Society and Vice President of Gulf Intervention Society. He is a Fellow of royal college of physicians UK, American college of physician, European society of cardiology, American college of cardiology, American society of cardiac intervention and fellow of the American heart association. Professor Shehab is the Chief Editor of Emirates Medical Journal and also serves as Editor in many other regional and international journals. Dr. Shehab has published 149 paper in Medline. His research interest includes: Heart failure, Coronary artery disease, Dyslipidaemia, Hypertension, Arrhythmias, Cardiac intervention, Cardiac imaging, Screening for cardiac disease in sport players, cardiovascular disease in pregnancy.
Dr. Elnour has received his PhD in School of Pharmacy, Queen's University Belfast, N. Ireland-United Kingdom during the period of 2000-2004. Currently, he is working as Assistant Professor in Alain university. Abu Dhabi campus. He also served as a researcher and research supervisor for assisting the PhD and MSc postgraduate students at several universities (25 Master students and 2 PhD students). He was honored as Editor of Medicine (Baltimore), Editorial board in many Journals and Regional editor. He is also serving as a reviewer in American Journal of Pharmaceutical Education-AJPE since 2008. He is former associate professor of Clinical Pharmacy, and Pharmacy Program Lead at Fatima College of Health Sciences, Al Ain-UAE and former adjunct Clinical associate professor in Pharmacology Department at United Arab Emirates University-UAEU. He has authored 100 research articles, Meta- analysis and Editorial Letters. He is a member of several professional and therapeutics committees like UAE University Ethics and Research Committee.
Dr. Akshaya Bhagavathula obtained his Pharm D with honors from Jawaharlal Nehru Technological University, India and fellowship of infectious diseases from Mandela children hospital, South Africa. He is an author of over 100 articles and books, as well as presented his research in several international conferences. He is also an editorial member of several high impact international journals. Currently, he is doing his research with Professor Abdullah Shehab to understand the gender disparities in cardiovascular risk factors and developing a new risk reduction scale for the secondary prevention of CVD in UAE population at UAE University, College of Medicine and Health Sciences, Al Ain, UAE.
Dimitri P. Mikhailidis graduated from the University of London (BSc, MSc, MB,BS and MD) and is Academic Head, Department of Clinical Biochemistry, Royal Free Hospital campus, University College London Medical School. He is also a Visiting Professor at the University of Belgrade, Serbia and at two universities in Saudi Arabia. His research interests are dyslipidaemias and thrombosis. He is a Fellow of the Royal College of Pathologists (FRCPath), Royal College of Physicians (FRCP), Faculty of Pharmaceutical Medicine (FFPM) and American College of Clinical Pharmacology (FCP). He has 22,093 citations on the ISI index, Core Collection (H-factor 64).
Dr. Manzoor Ahmed is an experienced Diagnostic Neuro-radiologist with more than 15 years of experience. Dr. Ahmed got his medical degree from Khyber Medical College, Pakistan in 1995 and later, trained in Cleveland Clinic, Ohio, USA in Diagnostic Neuro-radiology in 2003-2004. He is currently working in Sheikh Khalifa Medical City, Abu Dhabi, UAE. Dr. Ahmed is a passionate teacher and participant in academic activities. He has been involved as a speaker and organizer in multiple national and international meetings in the Gulf region. His special interests are in Diagnostic neuroradiology, Acute Stroke Imaging, Multiple Sclerosis and Head & Neck Imaging. His publications reflect his passion for neuroradiology. On the non-interpretive side, he is an ardent advocate for appropriateness in imaging. He believes “Radiology harbors much more potential than just images”.
Prof. Mona Alrukhaimi is a Professor of Medicine at Dubai Medical College, United Arab Emirates, Consultant physician & Nephrologist and Director of Alrukhaimi Polyclinic and Ex-Head of Medical and Renal Department, Dubai Hospital. She is the current President of the Emirates Medical Association Nephrology Society, Ex-Vice-president of Arab society of Nephrology & Renal Transplantation and the leader of the KDIGO Implementation Task Force for the Middle East & African Regions. She is the first female Nephrologist and Internist in UAE. She graduated from the University of Kuwait in 1983 and subsequently received her MRCP (UK) in 1989, FRCP Edinburg - 2001 and FRCP London – 2005. She has received various prestigious awards, including the Ministry of Education Award, UAE (1976) and many other awards.
Dr. Faraz Khan is presently serving as a Consultant Hematologist and Medical Oncologist at the American Hospital in Dubai. He is also a board member for the Emirates Hematology Society. He completed his postgraduate medical training from the University of Connecticut, USA and is triple US Board Certified in Internal Medicine, Medical Oncology and Hematology. Dr. Khan worked as a Consultant Medical Oncologist/Hematologist at PEI Cancer Treatment Center, Canada, where he also served as a primary investigator for the clinical trials in Hematologic diseases.
Dr. Hamda is a Consultant Family Physician in Dubai Health Authority. She is the Head of Medical Research Section in the Medical Education and Research Department and the Vice-President of the Emirates Family Medicine Society in the Emirates Medical Association. She is also the Vice-Chair of the MRCGP[INT] Exam Board and a member in the Dubai Scientific Research Ethics Committee.
Dr. Kim is currently working as a consultant physician of Anatomic Pathology at H.H. Sheikh Khalifa Specialty Hospital (SKSH), Ministry of Presidential Affairs, Ras Al Khaima UAE. He graduated from College of Medicine, Seoul National University (SNU) in 1998 and completed training anatomic pathology at Seoul National University Hospital (SNUH) in 2003. He served as a pathologist and researcher in Armed Forces Hospital, Korea, clinical professor at SNUH, Korea and Gachon University Hospital, Korea, director of molecular pathology at GC Labs. His interests are in biomarker discovery and development, molecular pathology of solid tumor which can be found in 21 international publications and 2 international patents. He has an experience in leading a project, centralized HER-2 retesting program, in Korea and in global clinical trial of lung cancer with ROS1 translocation. His main interest is in applying molecular pathology test using next generation sequencing (NGS) technology.
Prof. Chen is a Principal Investigator at Cancer Biology & Experimental Therapeutics Theme, School of Biomedical Sciences, CUHK. He is also the Principal Investigator at Shenzhen Research Institute, CUHK at Shenzhen. He is actively involved in molecular biology of pancreatic cancer and liver cancer. He is also an active reviewer of multiple grant agencies and peer-reviewed journals.
Dr. Khalid Alnaqbi is a Consultant and Head of Rheumatology and Immunology, at Al Ain hospital, UAE and he is also serving as the Vice President of Emirates Society for Rheumatology. He graduated from the College of Medicine and Health Sciences, UAE University and he further completed his postgraduate residency training at the University of Toronto in Internal Medicine and Rheumatology and then undertook a fellowship at the Spondyloarthritis Program. He holds multiple board certifications in Internal Medicine and Rheumatology (American Board of Internal Medicine, and the Royal College of Physicians and Surgeons of Canada, RCPSC). Dr. Alnaqbi pursued his academic interests by completing the Clinician Investigator Program with a thesis-based Master of Science (MSc). He has published in peer-reviewed journals and wrote a book chapter on ankylosing spondylitis. He is a journal reviewer in different prestigious scientific journals.
Mohamed B Abdelraheem Elfakky MD, FRCP, is a consultant of pediatric nephrology at Al Qassimi Women and Children's Hospital, Ministry of Health, Sharjah, UAE. He is also an adjunct Ass. Professor of pediatrics at the faculty of medicine, Sharjah University. Mohamed completed his MD in pediatrics and child health from the University of Khartoum. He did training in pediatric nephrology from Sheffield and Nottingham, UK, where he obtained his Master’s degree in medical science in nephrology and was also awarded the International Society of Peritoneal Dialysis ISPD fellowship. He worked previously at the University of Khartoum and Soba University Hospital, Khartoum, Sudan, where he, with other colleagues, established the 1st pediatric nephrology unit. He then joined the multi-organ transplant centre, King Fahad Specialist Hospital, Dammam, Saudi Arabia, for 2 years. He also worked at Al Jalila Children's Speciality Hospital, Dubai, before his current job at Al Qassimi Women and Children's Hospital, Ministry of Health, UAE. He is a member of the International Pediatric Nephrology Association (IPNA), the European Society of Pediatric Nephrology (ESPN), and the African Pediatric Nephrology Association (AFPNA). He published more than 28 research papers and contributed to chapters in textbooks and Acute Kidney Injury AKI, ISPD guidelines. Mohamed also participated in many regional and international meetings, including lectures, workshops, and seminars. In 2015, he was awarded the FRCP by the Royal College of Physicians for his significant contribution to pediatric nephrology in his country and developing African countries.
Professor Wael is a Full Professor of Molecular Pathology at the College of Health Sciences, University of Sharjah. He has been the coordinator of the MSc/PhD program in Molecular Medicine for 7 years. He is a board member of high impact scientific journals and acts as a chair or member in many research awards, grants and faculty promotion committees. Altogether, he has more than 30 years of work experience and 60 scientific articles and critical reviews on the genetics of colorectal, breast, and other cancers (H Index: 29, total citations: 2632). He has received more than 10 awards and 35 grants. His PhD work was carried out at Edinburgh and Cambridge Universities, UK (1997-2001), during which he identified a novel molecular cytogenetic profile in colorectal cancers. At the Department of Medical Genetics, University of Helsinki, Finland (2002-2007), he directed his efforts to the study and diagnosis of familial cancers and contributed to seminal discoveries in this field. Currently, his research at the University of Sharjah aims to understand the causes and mechanisms of cancer development in the region and the resistance of cancer cells to therapy; with a focus on the role of environmental pollutants and obesity in carcinogenesis.
Dr. Khaled Abuhaleeqa, MD, FRCSC, is presently serving as the Chief of Service at the Department of Ophthalmology Sheikh Shakhboot Medical City- Abu Dhabi, UAE (the largest Health Facility in the Country). He is a Board Certified and Fellowship Trained Consultant Ophthalmologist, specialized in plastic ophthalmic and reconstructive surgery. He earned his medical degree from the Royal College of Surgeons in Ireland in 1998. Dr. Abuhaleeqa received his Ophthalmology Residency Training at the University of Toronto. Academically, Dr. Abuhaleeqa attained the position of Residency Program Director for ophthalmology and Academic Affair Department Chair for many years. He is currently the General Secretary of the Emirates Society of ophthalmology and President of the ESO 2019 Conference.
Dr. Sawsan Abuhamdah is a Jordanian Registered Pharmacist, who graduated from Durham University, United Kingdom, 2007 (BSc, MSc, and PhD), and postdoctoral studies from Granada Medical School, Department of Pharmacology, Spain 2009 and has won postdoctoral Fulbright Research Award at the University of Toledo, Department of pharmacology and Experimental therapeutics, USA, 2014. She is now an associate professor of pharmacology and Therapeutics, College of Pharmacy, Al Ain University, Abu Dhabi UAE and faculty of Pharmacy, The University of Jordan / Jordan (On Leave). Dr. Abuhamdah has published more than 40 original research articles in peer-reviewed journals and participated in the preparation of many symposium abstracts in the field of pharmacology. Dr. Abuhamdah is a member of the British Pharmacological Society (BPS), British Neuroscience Association (BNA), American Society of Neuroscience (SFN), Sigma Phi Sigma Pharmaceutical Sciences Honor Society, USA and she has been serving as a regular reviewer for several medical journals, different funding agency and an editorial board member of reputable pharmaceutical journals. She has 770 citations on the ISI index, Core Collection (H-factor 15).
Prof. Suhad S. Abumweis holds a Ph.D. degree in Human Nutrition from McGill University (Montreal, Canada). She has worked in the Department of Clinical Nutrition and Dietetics at the Hashemite University since 2008. Currently, she is the director of the Nutrition and Dietetics program at Al Ain University, UAE. Her teaching interests are in nutritional assessment and medical nutrition therapy. Prof. Abumweis has clinical research experience, particularly in the area of functional foods and lipid metabolism. She has a good knowledge of strengths, limitations, and areas of potential improvement in human nutrition trials. In addition, she is conducting meta-analysis research on dietary interventions to reduce risk factors for chronic diseases. Prof. Abumweis has published 40 peer-reviewed research articles. Her work has been cited by regulatory authorities including the United State Food and Drug Administration, Health Canada, and the European Food Safety Authority. Her research interests are lipid metabolism, functional foods, nutraceuticals, health claims, evidence-based medical nutrition therapy, systematic reviews, and meta-analysis.
Prof. Aburuz is the Professor of Clinical Pharmacy and Pharmacotherapy at the College of Medicine at UAEU. He is currently the PharmD Program Director at the College of Medicine. He earned his PhD in Pharmacotherapy and Clinical Pharmacy from the School of Pharmacy, Faculty of Medicine and Health Sciences, Queens University Belfast, The United Kingdom, 2003. Prof. Aburuz held many administrative positions during his 18 years of academic and clinical carrier, including director, head of department, assistant dean, and vice dean. The main aims of his research and practice are to promote evidence-based medication use and prescribing to improve disease control and health-related quality of life of patients with chronic diseases. Prof. Aburuz has more than 70 publications in scientific international journals in the fields of Medicine and Clinical Pharmacy. Professor Aburuz has been awarded the distinguished researcher award four times. He supervised more than 30 research projects for PharmD, Master, and PhD students. Prof. Aburuz has developed and established clinical pharmacy services at the University of Jordan Hospital and also at Ibn Alhaythem hospital in Amman, Jordan. He has served as a clinical pharmacist and head of clinical pharmacy service for more than 10 years. He also served as a consultant for the Jordanian FDA in several committees, such as the clinical studies committee and Bioequivalence committee.
Dr. Mohamed Al-Olama, is a consultant Neurosurgeon at Rashid Hospital, DHA, Dubai, UAE. He is the Vice President of Emirates Medical Association. Dr. Al-Olama is also serving as the president of Emirates Society of Neurological Surgeons and gulf neurosurgical society. He is the General Secretary of Arab Pediatric neurosurgical society.
Dr. Artaman is an epidemiologist with years of experience in clinical, public, and global health epidemiology. He previously worked as a director in the public sector, a researcher in academia, and a consultant in the private sector. He was formerly an Assistant Professor at the University of Manitoba (Canada), and a WHO (EU, IARC) consultant and collaborator. He was also a visiting professor at universities in Thailand, Kazakhstan and the UAE. He is currently an expert for the Global Burden of Disease Study.
Dr. Baraka is currently an associate professor of Clinical Pharmacy in the College of Pharmacy, Al Ain University in Abu Dhabi, UAE. He was the head and founder of the Pharmacy Practice department in the College of Clinical Pharmacy, in Imam Abdulrahman Bin Faisal University (IAU) in KSA and a member of the college council for four years. He got his PhD in Clinical Pharmacy from the College of Medicine and Pharmacy, Free University of Brussels in Belgium 2011. He has several publications in Clinical Pharmacy practice and education. He is a member of the International Pharmaceutical Federation (FIP), in the American Association of Colleges of Pharmacy (AACP) and a volunteering member in the evaluation team of the American Accreditation Council of Pharmacy Education (ACPE).
Dr. BASSAM BERNIEH is presently serving as a Consultant Nephrologist at Mediclinic Al Ain Hospital, Consultant Nephrologist and Chief Nephrology at The Heart Medical Center, Al Ain, UAE, and Clinical Professor of Medicine, CMHS UAE University. He has been awarded a degree of MD from Aleppo University Aleppo, Syria in 1981. His clinical experiences include clinical nephrology, Systemic diseases, diabetic nephropathy, hypertension, chronic kidney disease, acute kidney injury, ICU nephrology, kidney transplantation, home hemodialysis, hemodialysis, peritoneal dialysis and CRRT & TPE. He has contributed 43 papers in peer reviewed journals, and 36 oral and poster presentations at international conferences.
Dr. Khawla M. Belhoul is a Fellow of The Royal College of Physicians UK, a consultant hematologist with extensive experience in benign hematology at Dubai Health Authority. She is also an Adjunct Clinical Associate Professor at the College of Medicine MBRU and Director of hematology fellowship program at DHA. Her clinical and research interests focus on hemoglobinopathies. Under her leadership, the Thalassemia Center received the DHA Best Customer satisfaction award in 2017, the Arab Health Award of Excellence in Patient Centered Care, Sheikh Sultan National Award of center of excellence in patient care in 2013, and the best research team award in DHA in 2016. Dr. Khawla has authored and co-authored several articles published in international peer-reviewed journals and was the key speaker in many national and regional conferences. She played a vital role in the establishment of emirates society of hematology and in the initiation of the emirates hematology conference and PATH conference.
Dr. Everett is a professor at the Department of Pathology and Infectious Diseases, College of Medicine and Health Sciences, Khalifa University (KU), and is a member of the Emirates Society of Clinical Microbiology’s Scientific Committee. Dr. Everett previously held the post of Professor of Molecular Microbiology and Global Health at the University of Edinburgh (UK) before joining KU. Prior to his arrival in Abu Dhabi, Dr. Everett spent 23 years undertaking clinical research as a UK academic-based full-time professor in Africa. Dr. Everett earned his Ph.D. from the London School of Hygiene and Tropical Medicine (UK) and has research interests across a broad range of pathogens encompassing a number of scientific disciplines (microbiology, molecular biology, molecular microbiology, host and pathogen genomics, clinical-based research, clinical trials, surveillance, and vaccine discovery).
Dr Egred is a Consultant Interventional Cardiologist at the Freeman Hospital and Honorary Senior Lecturer at Newcastle University, UK. He is a high volume operator and a specialist in complex coronary interventions, chronic total occlusion and the use of adjunctive devices such as Laser, Rotablation, and intravascular imaging in addition to valves intervention. He is an educator, physician trainer and a proctor in multiple complex coronary interventions including chronic total occlusion, LASER, Rotablation, left main stem bifurcation, and IVUS and conducts regular training courses and proctorship around the globe. He is a regular faculty member and live case operator of many international educational meetings. He has over 80 papers, articles, reports and over 70 abstracts and oral presentations. He is a member of the British Cardiac Society and the British Cardiac Intervention Society, the Royal College of Physicians UK, the European Society of Cardiology, and the European Association of Percutaneous Coronary Intervention. He served until recently as the clinical and educational section editor of the Journal of the Royal College of Physicians of Edinburgh and is a regular reviewer for major international journals.
Ahmed Ibrahim Fathelrahman is currently an associate professor at the Department of Clinical Pharmacy, College of Pharmacy, Taif University, Saudi Arabia. He is the main author or co-author of more than 50 articles and titles representing publications in international peer-reviewed journals, books, book chapters, or conference presentations. He is the author of three books, which were co-edited by Professor M Izham Mohamed Ibrahim from Qatar University and Professor Albert Wertheimer from College of Pharmacy, Nova SE University, US. Those books are “Pharmacy Practice in Developing Countries: Achievements and Challenges” (published in 2016 by Academic Press an imprint of Elsevier Science), "Pharmacy Education in the Twenty First Century and Beyond: Global Achievements and Challenges" (published in 2018 by Academic Press an imprint of Elsevier Science), and “Medical Devices for Pharmacy and Other HealthCare Professions” (published this year i.e. 2022 by CRC, Taylor and Francis Group). Ahmed Fathelrahman is a reviewer for a variety of international journals related to Pharmacy, Public Health, Tobacco Control and Toxicology and he acted as a member of review committees for a couple of international scientific meetings organized by the International Society of Pharmacoeconomics & Outcomes Research (ISPOR) and the Society for Research on Nicotine & Tobacco (SRNT). He is currently an editorial board member for the International Journal of Clinical Pharmacy affiliated with the European Society of Clinical Pharmacy and published by Springer Nature. In addition, he supervised the research of about 50 medical or pharmacy students in Sudan and Saudi Arabia at levels of Bachelor, Pharm D, M.Sc., MD and Fellowship.
Emadeldin Ibrahim is the Professor of Pulmonary Medicine at the Department of Pulmonary Medicine, Alexandra Faculty of Medicine, Egypt. He also serves as the Consultant Pulmonologist, at the AlZahra Hospital, UAE. Dr. Ibrahim received his doctoral degree in Pulmonary Diseases (Ph.D.), Alexandria University, Egypt in 2002. He has received several awards and honor in recognition of his excellence in the field of pulmonary medicine. Dr. Ibrahim has published several peer-reviewed articles in prestigious journals including Chest and Critical Care Medicine.
Dr. Iftikhar Ahmed Jan has been serving as a Professor of Pediatric Surgery since 2005. His qualification includes FRCS, FRCSEd, FACS, FEBPS and FCPS. He has contributed more than 70 research publications & made hundreds of presentations in national and international conferences. He has been recognized with distinguished Surgeon Award 2019 by DHA, SEHA, Best 100 employees award in 2019, Best 1000 employees award in 2018 and other awards. His skills and expertise are in Pediatric Minimally Invasive Surgery, Thoracoscopic Surgery, General Pediatric Surgery, Pediatric Endourology, Neonatal Surgery, Pediatric GI and airway endoscopies.
Neuroscientist (Clinical & Pre-clinical) with over 10 years of successful experience in In vitro (mammalian and human) and in vivo (mice, rat, and rabbit) experiments. According to Stanford and Elsevier reports, he has been listed among the top 2% of scientists in the world (2021). He has been recognized consistently for his outstanding performance, initiatingpotential international collaborations, highly-cited publications, and contributions to academic research. Rodent operations, insilico drug discovery, protein aggregation investigations, molecular biology, pharmacokinetics, and pre-clinical procedures are among his strengths, which are backed up by post-doctoral training from the United States. He also attended certified NIH (USA) grant writing workshops and Neuroscience certificate courses from Harvard University and Swiss Federal Institute of Technology.
Dr. Kumar has more than 13 years of clinical experience in the field of Neurosurgery. He completed his MBBS in 2002 from Pakistan and started his fellowship training at Jinnah Post Graduate Medical Centre (JPMC) Karachi in 2004. In 2007, he started Neurosurgery training at Agha KHAN University Hospital Karachi, Pakistan and was awarded as best graduating neurosurgery resident by faculty in 2011 and was promoted to Instructor Neurosurgery in 2012. He completed his FCPS (Neuro Surgery) in 2011 from College of Physicians and surgeons Pakistan and European fellowship of neurosurgery (FEBNS) in January 2018 and MRCPS (Glasgow) in 2020. He also worked with many prestigious intuitions including Agha Khan University Hospital, National Medical Centre and Liaquat National Hospital & Medical College in Karachi. Prior to joining Zulekha Hospital Dubai, he worked as a Specialist Neurosurgeon at Rashid Hospital, Dubai for 4 years. He was elected as General Secretary of the Emirates Society of Neurosurgical Surgeons and is also a member of the World Spinal Column Society, North American Spine Society , AO spine, Royal College of Physicians and Surgeons Glasgow, American College of Surgeons and Emirates Medical Association. He has presented multiple papers in national and international conferences and has chaired many sessions. Presently, he is involved in nursing education and undergraduate medical education.
Joseph F. Maalouf, M.D. is a cardiologist with a special interest in echocardiography,
multimodality imaging, and structural heart diseases, including valvular heart disease for his
clinical practice, research, and education.
His clinical focus is on echocardiography for reliable diagnosis and management of all CV diseases using transthoracic, transesophageal (2-D, 3-D) and stress (for ischemia, valvular heart disease, and diastolic dysfunction) echocardiography, evaluation and management of patients with valvular heart diseases, and coordinating the care of patients undergoing complex valvular disease interventions, including transcatheter aortic valve replacement and mitral clip procedures. Currently, Dr. Maalouf is the Department Chair of Cardiovascular Diseases at Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, UAE.
Dr. Godfred A. Menezes did his Masters in Medical Microbiology and Immunology from Kasturba Medical College, Manipal India, in 2003. He further received his Ph.D. in Medical Microbiology at JIPMER. He has worked in 3 different Medical Colleges in India; SSR Medical College, Mauritius; Erasmus MC, Rotterdam, The Netherlands & Ha’il University, Ha’il, Saudi Arabia. He has more than 60 research publications in reputed journals to his credit with more than 1000 citations with 17 h-index. He is an active committee member of various committees. He has also been serving as an editorial board member of different reputed journals. He had delivered more than 30 lectures in national and international conferences.
I received my Ph.D. from Annamalai University, Tamil Nadu, in 2015, where I studied the cardioprotective effects of natural sesquiterpene thymol in the animal models of myocardial infarction in the Department of Biochemistry and Biotechnology with Dr. P. Selvaraj. Then, I moved to the Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, the United Arab Emirates as a Post Doctoral Research Associate in Prof. Shreesh Ojha Lab (2016-present). Our research focuses on the effect of naturally derived and synthetic compounds and their mode of action and effective mechanisms at the molecular levels of cardiovascular, kidney, liver, and brain-related complications. My other objective is to identify new targets for discovering improved therapies to treat myocardial ischemia, neurodegenerative diseases, and chemotherapy-related complications.
Atul C. Mehta, M.D., F.A.C.P., F.C.C.P. is a Professor of Medicine at the Lerner College of Medicine, Buoncore Family Endowed Chair in Lung Transplantation, Staff Physician, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA. He graduated from Municipal Medical College, Gujarat University India. He completed his Residency Training in General Practice from the Delaware County Memorial Hospital, Drexel Hill, PA, USA. He received his board-certification in Internal Medicine, Pulmonary Disease, Interventional Pulmonology, (Critical Care Medicine) etc. His research interests span from Diagnostic & therapeutic bronchoscopy, Lung transplantation, and Emphysema. He received a number of awards such as in 1992, he got the Cleveland Clinic & Bruce Steward Award for ability to combine sensitivity & compassion with knowledge & skill; in 2005, he got the Presidential Citation Honor Lecture Award, ACCP etc. He was the founding member and Past-President of the American Association for Bronchology & Interventional Pulmonology and fellow of the ACCP, ACP, and the American Society for Laser Medicine & Surgery. He participated in numerous clinical trials and has published over 500 peer reviewed papers, over 100 book chapters, and edited and authored 18 books.
Dr. Wael Mohammed Osman holds a degree in Medicine from the University of Khartoum, Sudan, and a PhD in Molecular Pathology from the University of Tokyo, Japan. He also holds a Post-Graduate Certificate in Clinical Research from Harvard Medical School, USA, and is enrolled in an MSc program in International Public Health at Liverpool John Moores University, UK. His research focuses on the epidemiology and genetics of metabolic traits (type 2 diabetes, obesity, and cardiovascular disease, complications of diabetes, in particular, diabetic kidney disease (DKD). Recently, he established a UAE-based research group for metabolic diseases related to maternal health, with a particular focus on gestational diabetes mellitus. His research involves the analysis of clinical data in integration of genetic data.
Hyo Jin Park, M.D., Ph.D. is a consultant pathologist at Sheikh Khalifa Specialty Hospital (SKSH). She is affiliated to Seoul National University (SNU) Hospital in Korea as a clinical assistant professor. Dr. Park received M.D. degree from SNU, College of Medicine in 1998 and her Ph.D. from SNU, College of Medicine in 2010 with the thesis of “T cell development in genetically engineered mouse”. After undertaking an internship at SNU Hospital, she did her residency in pathology at the same hospital. From 2011, as a Clinical Assistant Professor in Pathology Department at SNU Bundang Hospital, her research and clinical activity is focused on endocrine, bone/soft tissue pathology, immunology and molecular pathology. She has worked at Sheikh Khalifa Specialty Hospital, pathology department from 2015 in which genetic test on solid tumor using next generation sequencing was implemented successfully under supervision of Dr. Park. She has published a number of articles in SCI journals.
She graduated from the Faculty of Medicine, Alexandria University, Egypt, with an MSc and PhD in Basic Medical Sciences in Pathology. Then, she joined the Pathology Department, Alexandria Faculty of Medicine in 1999, and maintains a faculty appointment as Full Professor of Pathology since 2018. She has been appointed as an Associate Professor in the Clinical Sciences Department, College of Medicine, University of Sharjah, UAE, since 2016. Moreover, she is a consultant histopathologist with a primary interest in general surgical pathology and a special interest in breast, GIT, and renal pathology. Her research work in the field of cancer focuses mainly on breast, colorectal, prostate, and renal cancer. She has good experience in immunohistochemistry (IHC), in-situ hybridization (ISH), and fluorescence in situ hybridization. She has publications in different national and international peer-reviewed journals. She is also the PI and co-PI of different internal and external grants awarded for cancer research.
Dr. Sami El Khatib is an Associate Professor, Assistant Dean of the School of Arts & Sciences at the Lebanese International University (LIU). Dr. El Khatib is a PhD in Cell Biology and Oncology (2005), a Master Degree in Bioengineering & Biomaterials (2002), a University Diploma in Animal Experimentation (2003) from Henri Poincare University in France, and a BS in Medical Laboratory from Lebanese University (2000). His research work has been focused on the non-invasive techniques of diagnosis and treatment of Bladder Cancer published in highly ranked international peer reviewed journals. He published his first work conducted in vivo aiming at the use of HexvixÒ (Hexyl-aminolevulinate - hALA) as a pro-drug, a precursor of the Protoporphyrin IX (PpIX) mediating the Photodynamic treatment of bladder cancer in rats. His additional works are focused on the photodynamic diagnosis and the photobleaching kinetics of Hexvix-induced PpIX was also conducted. Dr. El Khatib is currently working on many topics related to Molecular Biotechnology & Genome Editing Strategies. He is also supervising many Master's students working on health benefits of food, food extracts, and fortification strategies. Dr. El Khatib has authored and co-authored numerous conference articles, books, book chapters in the aforementioned scientific topics. Dr. El Khatib is a member of the Middle East Molecular Biology Society, a member of MEMBS International Advisory Committee.